Brief: Movano Health Files First FDA Submission For Its Smart Ring's SpO2, Heart Rate Data

Corvex

14/12/2022 14:41

Dec 14 (Reuters) - Movano Inc  MOVE.O :
    * MOVANO HEALTH ON TRACK TO FILE FIRST FDA SUBMISSION FOR
ITS
SMART RING'S SPO2 AND HEART RATE DATA FOLLOWING SUCCESSFUL
PIVOTAL HYPOXIA TRIAL
    * PRELIMINARY RESULTS DEMONSTRATED HIGH ACCURACY OF SPO2 AND
HEART
RATE DATA IN ITS PIVOTAL HYPOXIA TRIAL
    * GIVEN THESE POSITIVE RESULTS, MOVANO HEALTH EXPECTS TO
FILE FOR
FDA CLEARANCE OF THESE METRICS IN 2023

Source text for Eikon:  ID:nPn4DbmTka 
Further company coverage:  MOVE.O 
 ((Reuters.Briefs@thomsonreuters.com;))